ASCO's Clinical Cancer Advances

Source Date: 
Wed, 2015-01-21

WED, Jan 21st -- UC Davis professor Moon Chen’s research on the under-representation of minorities in clinical trials appears in the American Society in Clinical Oncology (ASCO)’s annual cancer progress report released Tuesday.

Assessing the year’s major achievements and emerging trends in clinical cancer research and care, the Clinical Cancer Advances 2015: ASCO’s Annual Report on Progress Against Cancer shows that despite The National Institutes of Health (NIH) Revitalization Act of 1993, which mandates appropriate representation of women and racial/ethnic minorities in NIH-funded clinical research studies, the proportion of racial/ethnic minorities participating in cancer clinical trials is persistently lower than the proportion of minorities in the overall U.S. population.

Minorities are disproportionately burdened with cancer, said Chen, lead author and the cancer center’s associate director for disparities and research. The need for adequate participation in cancer research is greater than...


To see the full article, please visit the UC Davis Comprehensive Cancer Center site here.

To view the ASCO Press release, please visit here. To download the full ASCO's Annual Progress Report on Progress Against Cancer, you may donwload it here.